Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bernhard Lämmle, M.D.
University Medical Center, Center for Thrombosis and Hemostasis, Mainz, Germany
Study Chair - Ingrid Hrachovinova, Ph.D.
Institute of Hematology and Blood Transfusion, Coagulation Laboratory, Prague, Czech Republic
Study Chair - James N. George, MD
University of Oklahoma Health Sciences Center, Department of Medicine, United States of America
Study Chair - Johanna A Kremer Hovinga, MD
University Clinic of Hematology and Central Hematology Laboratory, Bern University Hospital and the University of Bern, Inselspital
Study Chair - Paul N Knoebl, MD
Medical University of Vienna, Div. Hematology and Hemostasis, Austria
Study Chair - Petter Quist-Paulsen, M.D., Ph.D.
Department of Hematology, St Olavs Hospital, 7006 Trondheim, Norway
Study Chair - Reinhard Schneppenheim, M.D., Ph.D.
Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Study Chair - Yoshihiro Fujimura, M.D.
Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medical University of Vienna, Department of Medicine 1, Div. Hematology and Hemostasis Waehringer Guertel 18-20
Vienna, Austria
Paul N. Knoebl, M.D.Recruiting
- Institute of Hematology and Blood Transfusion, Coagulation Laboratory, U Nemocnice 1
Prague, Czechia
Ingrid Hrachovinova, Ph.D.Recruiting
- University Medical Center Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Martinistr 52
Hamburg, Germany
Reinhard Schneppenheim, M.D., Ph.D.Not, yet, recruiting
- Nara Medical University, Department of Blood Transfusion Medicine, Shijyo-Cho 840
Kashihara, Nara, Japan
Yoshihiro Fujimura, M.D.Recruiting
- Trondheim University St Olavs Hospital, Department of Hematology, Po Box 3250 Sluppen
Trondheim, Norway
Anne-Sophie von Krogh, M.D.Petter Quist-Paulsen, M.D.,Ph.D.Recruiting
- University Clinic of Hematology and Central Hematology Laboratory, Bern University Hospital and the University of Bern, Inselspital
Bern, Switzerland
Johanna A Kremer Hovinga, MDRecruiting
- University of Oklahoma Health Sciences Center, Department of Medicine, Po Box 26901
Oklahoma City, Oklahoma, United States
James N. George, M.D.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2006
- Primary completion
- 31 Oct 2030
- Completion
- 31 Oct 2030
- Last update posted
- 11 Oct 2023
- Registered enrollment
- 450
- Registry id
- NCT01257269
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.